FDA panel to examine menthol cigarettes' impact

RICHMOND, Va. — A new U.S. Food and Drug Administration panel will take a closer look at menthol cigarettes and how the government should regulate them, but most believe an outright ban is unlikely.

The tobacco industry is keeping a close eye on the committee's work and its recommendations for menthol, a still-growing part of the shrinking cigarette market.

When it meets Tuesday and Wednesday, the committee will discuss the scientific research on the public health effects of menthol cigarettes, including among children and certain ethnic groups. The panel is to make recommendations by next March.

The FDA won the authority in June to regulate tobacco, including banning certain products, limiting nicotine and blocking labels such "low tar" and "light" that could wrongly imply certain products are less harmful. The law doesn't let the FDA ban nicotine or tobacco entirely.

Matthew Myers, president of the Campaign for Tobacco-Free Kids, said the overriding goal must be reducing the number of people who die from tobacco use.

"This is the first time that all of the science will be brought together looking at whether menthol increases the number of users, makes it hard to quit, has a disproportionate harmful effect on certain people, and, if the answer to any of those questions is yes, what is the best thing to do about menthol to reduce the number of people who are harmed?" Myers said.

The committee of 12, including three nonvoting members representing the tobacco industry, is to advise FDA on a range of issues. Committee members also are later tasked with studying dissolvable tobacco products as well as product changes and standards. It's chaired by Dr. Jonathan Samet, director of the University of Southern California's Institute for Global Health and former director of the Institute for Global Tobacco Control at Johns Hopkins University.

The relative strength of the menthol market has cigarette makers introducing new menthol products and innovations.

The two largest cigarette makers — No. 1 Philip Morris USA, owned by Richmond, Va.'s Altria Group Inc., and No. 2 Reynolds American Inc., based in Winston-Salem, N.C. — are ramping up efforts to grab some of the menthol market away from Greensboro, N.C.-based Lorillard Inc., the nation's third-largest cigarette company. Lorillard holds about 35 percent of the U.S menthol market with its top-selling Newport brand.